© 2022 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Our October list includes potential pancreatic cancer treatments, hypothyroidism risks, and cost burdens of endocrine-disrupting chemicals.
We present a selection of interesting endocrinology articles for the month of October in the following slides. See the slide legends for links to the article summaries.
Sitagliptin and Risk of Fractures in Type 2 Diabetes: Results from the TECOS Trial. Abstract link.****Heavy Cannabis Use Is Associated with Low Bone Mineral Density and an Increased Risk of Fractures. Abstract link.
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. Abstract link.****Randomised, Open-Label, Phase II Study of Gemcitabine with and without IMM-101 for Advanced Pancreatic Cancer. Abstract link.
Highly Aligned Stromal Collagen Is a Negative Prognostic Factor Following Pancreatic Ductal Adenocarcinoma Resection. Abstract link.****Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth. Abstract Link.
Exposure to Endocrine-Disrupting Chemicals in the USA: a Population-Based Disease Burden and Cost Analysis. Abstract Link. ****Obesogens and Male Fertility. Abstract link.
Effects of Resveratrol on Polycystic Ovary Syndrome: a Double-blind, Randomized, Placebo-controlled Trial. Abstract link.****FDA Approves New Changes to Testosterone Labeling Regarding the Risks Associated with Abuse and Dependence of Testosterone and Other Anabolic Androgenic Steroids (AAS). FDA release.
Phototherapy and Risk of Type 1 Diabetes. Abstract link. **** Autoimmune Diseases in Children and Adults with Type 1 Diabetes from the T1D Exchange Clinic Registry. Abstract link.
Clinical Outcomes of Patients with Hypothyroidism Undergoing Percutaneous Coronary Intervention. Abstract link. ****Thyroid Function and Sudden Cardiac Death. A Prospective Population-Based Cohort Study. Abstract link.
Headache Disorders May Be a Risk Factor for the Development of New Onset Hypothyroidism. Abstract Link. ****Papillary Thyroid Microcarcinoma: Time to Shift from Surgery to Active Surveillance? Abstract link.